115 related articles for article (PubMed ID: 3464850)
1. [Usefulness of the determination of CA 19-9 in the follow-up of patients with gastroenteric neoplasms in comparison to CEA].
Pecchio F; Piantino P; Oliaro A; Rapellino M; Ricci E; Aimo G; Obert R
Minerva Med; 1986 Nov; 77(42-43):1973-81. PubMed ID: 3464850
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
Olsson NO; Crimet-Montange D; Martin F
Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
[TBL] [Abstract][Full Text] [Related]
4. [CA 12-5 in cancer of the digestive tract. A comparison with CA 19-9 and CEA in cancer of the pancreas and colon].
Klapdor R; Klapdor U; Bahlo M; Dallek M; Kremer B; van Ackeren H; Schreiber HW; Greten H
Dtsch Med Wochenschr; 1984 Dec; 109(51-52):1949-54. PubMed ID: 6595110
[TBL] [Abstract][Full Text] [Related]
5. [Estimates of circulating breast cancer-associated antigen CA 15-3 as a monitoring marker in patients with breast cancer].
Yoshimoto M; Akiyama F; Watanabe S; Kasumi F; Fukami A; Nakajima T; Nishi M; Kajitani T; Takahashi S
Gan To Kagaku Ryoho; 1987 Jul; 14(7):2310-5. PubMed ID: 3475042
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of the efficacy of the combined determination of serum markers CEA, CA 19.9, CA 72.4 as indexes of gastro-intestinal tract neoplasms].
Marchei P; Cifaldi L; De Benedetto A; Santini D; Manna A; Trasatti L; Marchei GG; Reale MG
G Ital Oncol; 1990; 10(4):121-4. PubMed ID: 2093080
[TBL] [Abstract][Full Text] [Related]
7. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
Tappero G; Piantino P; Cerchier A; Pecchio F
Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of the circulating tumor-associated antigen CA 19-9 in cancers of the digestive tract].
Staab HJ; Hornung A; Anderer FA; Kieninger G
Dtsch Med Wochenschr; 1984 Jul; 109(30):1141-7. PubMed ID: 6204834
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system.
Sakamoto K; Haga Y; Yoshimura R; Egami H; Yokoyama Y; Akagi M
Gut; 1987 Mar; 28(3):323-9. PubMed ID: 3471687
[TBL] [Abstract][Full Text] [Related]
12. [CA 19-9 in neoplasms. Comparison with CEA].
Nakad A; Jonard P; Geubel A; Warzee P; Coppens JP; Dehennin JP; Dive C
Acta Gastroenterol Belg; 1987; 50(1):36-44. PubMed ID: 3480669
[No Abstract] [Full Text] [Related]
13. [Antigens CA-50 and CA-242 in digestive tract and thyroid neoplasms].
Pomorski L; Pasieka Z; Kołomecki K; Czyz W; Kołodziejczyk M; Wróbel B
Wiad Lek; 1997; 50 Suppl 1 Pt 1():18-20. PubMed ID: 9446350
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
[TBL] [Abstract][Full Text] [Related]
15. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies. Their usefulness in the diagnosis of malignant tumors of the digestive system].
Campos Campos F; Romero Navarro MA; Gutiérrez Samperio C; Esquivel P; Gaviño Chapa JF
Rev Gastroenterol Mex; 1989; 54(4):193-8. PubMed ID: 2616981
[TBL] [Abstract][Full Text] [Related]
17. [CA 15-3 in the diagnosis and monitoring of carcinoma of the breast and its correlations with CEA].
Festa V; Alabiso O; Piantino P; Lisa F; Zanini M; Garrone C; Simone P; Morino M
Minerva Chir; 1989 Mar; 44(6):1015-20. PubMed ID: 2733831
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of the determination of CEA and Ca 19-9 in the diagnosis and staging of bronchial carcinoma].
Rapellino M; Pecchio F; Baldi S; Obert R; Bevilacqua Rapellino A; Libertucci D; Coni F; Oliaro A
Minerva Med; 1987 Mar; 78(6):373-5. PubMed ID: 3470632
[TBL] [Abstract][Full Text] [Related]
19. [CA-50: evaluation of a new tumor marker in the diagnosis of neoplastic pathologies of the gastrointestinal tract].
Pecchio F; Ricci E; Rapellino M; Oliaro A; Adamo MR; Marzola G; Piantino P
Minerva Med; 1987 Feb; 78(3):141-4. PubMed ID: 3469541
[TBL] [Abstract][Full Text] [Related]
20. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
Schatz C; von Lieven H; Mulders M; Rowold J; Stracke H; Müller H; Grebe SF; Schatz H
Wien Klin Wochenschr; 1985 Dec; 97(23):873-9. PubMed ID: 3878042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]